Former U.S. President Joe Biden is currently receiving radiation therapy and hormone treatment as part of his ongoing care for metastatic prostate cancer, according to a spokesperson on Saturday. The 82-year-old Democratic leader, who turns 83 next month, revealed his diagnosis in May, describing the illness as aggressive but hormone-sensitive, meaning it is expected to respond positively to therapy.
Earlier in September, Biden underwent Mohs surgery, a procedure designed to remove cancerous skin cells, marking another step in his broader battle against cancer. His medical team confirmed that the current treatment regimen, which includes radiation therapy, is focused on slowing the spread of prostate cancer and managing symptoms effectively.
Prostate cancer remains one of the most common cancers among men, and Biden’s case highlights the importance of early detection and comprehensive treatment plans. Experts note that hormone-sensitive prostate cancers, while serious, often respond well to hormone therapy combined with radiation, offering patients better long-term outcomes.
Throughout his career, Joe Biden has been open about his health challenges, emphasizing the importance of transparency and preventive healthcare. His ongoing treatment has drawn attention to the advances in cancer therapy and the resilience often required to navigate such conditions at an advanced age.
Medical professionals stress that metastatic prostate cancer requires continuous monitoring and adaptable treatment strategies. Biden’s medical team has expressed optimism about his response to the current plan, though they acknowledge that radiation and hormone therapies can lead to side effects such as fatigue and hormonal changes.
With continued medical care and public support, Biden’s health journey underscores the broader conversation about cancer awareness, aging, and treatment innovations in modern medicine.


U.S. Lifts Sanctions on Brazilian Supreme Court Justice Amid Shift in Brazil Relations
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant
Belarus Frees Opposition Leaders Maria Kalesnikava and Viktar Babaryka in U.S.-Brokered Deal
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders
Preservation Group Sues Trump Administration to Halt $300 Million White House Ballroom Project
New Epstein Photos Surface Showing Trump as Lawmakers Near Document Release Deadline
International Stabilization Force for Gaza Nears Deployment as U.S.-Led Planning Advances
Global Leaders Condemn Deadly Antisemitic Shooting at Sydney’s Bondi Beach During Hanukkah
U.S. Intelligence Briefly Curtailed Information Sharing With Israel Amid Gaza War Concerns
Trump Signals Two Final Candidates for Fed Chair, Calls for Presidential Input on Interest Rates
Thailand Vows Continued Military Action Amid Cambodia Border Clash Despite Trump Ceasefire Claim
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee 



